Bridgepoint Group (LON:BPT) Stock Price Down 9.6% – Time to Sell?

Bridgepoint Group plc (LON:BPT) shares traded down 9.6% during mid-day trading on Wednesday . The stock traded as low as GBX 240.60 and last traded at GBX 240.80. 6,589,081 shares were traded during mid-day trading, a decline of 18% from the average session volume of 8,079,381 shares. The stock had previously closed at GBX 266.40.

Analyst Ratings Changes

Separately, Citigroup decreased their price objective on shares of Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating for the company in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Bridgepoint Group has an average rating of “Moderate Buy” and a consensus price target of GBX 385.

Bridgepoint Group Stock Up 1.9%

The company has a debt-to-equity ratio of 55.04, a quick ratio of 3.60 and a current ratio of 279.03. The firm has a market capitalization of £2.21 billion, a P/E ratio of 51.59, a P/E/G ratio of 0.61 and a beta of 1.36. The stock has a fifty day moving average price of GBX 254.81 and a two-hundred day moving average price of GBX 263.80.

Bridgepoint Group (LON:BPT) last released its quarterly earnings data on Thursday, March 12th. The company reported GBX 26.50 EPS for the quarter. Bridgepoint Group had a net margin of 7.68% and a return on equity of 4.25%. Research analysts forecast that Bridgepoint Group plc will post 17.4062165 EPS for the current year.

Insider Activity

In other Bridgepoint Group news, insider Michelle Scrimgeour purchased 21,616 shares of the firm’s stock in a transaction dated Thursday, March 12th. The stock was acquired at an average cost of GBX 230 per share, with a total value of £49,716.80. Insiders own 0.60% of the company’s stock.

About Bridgepoint Group

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.